401 related articles for article (PubMed ID: 33202867)
1. Rhabdomyolysis-Induced AKI Was Ameliorated in NLRP3 KO Mice via Alleviation of Mitochondrial Lipid Peroxidation in Renal Tubular Cells.
Song SJ; Kim SM; Lee SH; Moon JY; Hwang HS; Kim JS; Park SH; Jeong KH; Kim YG
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202867
[TBL] [Abstract][Full Text] [Related]
2. Inflammasome-Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal Injury.
Kim SM; Kim YG; Kim DJ; Park SH; Jeong KH; Lee YH; Lim SJ; Lee SH; Moon JY
Front Immunol; 2018; 9():2563. PubMed ID: 30483252
[TBL] [Abstract][Full Text] [Related]
3. Role of NLRP3 Inflammasomes for Rhabdomyolysis-induced Acute Kidney Injury.
Komada T; Usui F; Kawashima A; Kimura H; Karasawa T; Inoue Y; Kobayashi M; Mizushina Y; Kasahara T; Taniguchi S; Muto S; Nagata D; Takahashi M
Sci Rep; 2015 Jun; 5():10901. PubMed ID: 26045078
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of Drp-1 translocation.
Tang WX; Wu WH; Qiu HY; Bo H; Huang SM
J Nephrol; 2013; 26(6):1073-82. PubMed ID: 23553524
[TBL] [Abstract][Full Text] [Related]
5. Anisodamine inhibits endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in rhabdomyolysis-induced acute kidney injury.
Yuan X; Zheng Y; Chen C; Wang C
Apoptosis; 2017 Dec; 22(12):1524-1531. PubMed ID: 28918467
[TBL] [Abstract][Full Text] [Related]
6. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation.
Lin Q; Li S; Jiang N; Shao X; Zhang M; Jin H; Zhang Z; Shen J; Zhou Y; Zhou W; Gu L; Lu R; Ni Z
Redox Biol; 2019 Sep; 26():101254. PubMed ID: 31229841
[TBL] [Abstract][Full Text] [Related]
7. Numb Depletion Promotes Drp1-Mediated Mitochondrial Fission and Exacerbates Mitochondrial Fragmentation and Dysfunction in Acute Kidney Injury.
Liu Z; Li H; Su J; Xu S; Zhu F; Ai J; Hu Z; Zhou M; Tian J; Su Z; Yang P; Nie J
Antioxid Redox Signal; 2019 May; 30(15):1797-1816. PubMed ID: 29890853
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury.
Ding W; Guo H; Xu C; Wang B; Zhang M; Ding F
Oncotarget; 2016 Apr; 7(14):17479-91. PubMed ID: 27014913
[TBL] [Abstract][Full Text] [Related]
9. P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling.
Han SJ; Lovaszi M; Kim M; D'Agati V; Haskó G; Lee HT
FASEB J; 2020 Apr; 34(4):5465-5482. PubMed ID: 32086866
[TBL] [Abstract][Full Text] [Related]
10. Renoprotective effect of long acting thioredoxin by modulating oxidative stress and macrophage migration inhibitory factor against rhabdomyolysis-associated acute kidney injury.
Nishida K; Watanabe H; Ogaki S; Kodama A; Tanaka R; Imafuku T; Ishima Y; Chuang VT; Toyoda M; Kondoh M; Wu Q; Fukagawa M; Otagiri M; Maruyama T
Sci Rep; 2015 Sep; 5():14471. PubMed ID: 26412311
[TBL] [Abstract][Full Text] [Related]
11. Evaluations of lipid peroxidation and inflammation in short-term glycerol-induced acute kidney injury in rats.
Nara A; Yajima D; Nagasawa S; Abe H; Hoshioka Y; Iwase H
Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1080-1086. PubMed ID: 27529136
[TBL] [Abstract][Full Text] [Related]
12. mROS-TXNIP axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKI.
Wen Y; Liu YR; Tang TT; Pan MM; Xu SC; Ma KL; Lv LL; Liu H; Liu BC
Int J Biochem Cell Biol; 2018 May; 98():43-53. PubMed ID: 29477360
[TBL] [Abstract][Full Text] [Related]
13. Genetic inhibition of FABP4 attenuated endoplasmic reticulum stress and mitochondrial dysfunction in rhabdomyolysis-induced acute kidney injury.
Liu J; Huang R; Li X; Guo F; Li L; Zeng X; Ma L; Fu P
Life Sci; 2021 Mar; 268():119023. PubMed ID: 33434534
[TBL] [Abstract][Full Text] [Related]
14. LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis.
Yang Y; Meng L; Wu S; Li Y; Zhong Y; Xu F; Zhou XC; Li GQ; Xu GL; Peng KF
Int Immunopharmacol; 2020 Dec; 89(Pt A):106999. PubMed ID: 33045563
[TBL] [Abstract][Full Text] [Related]
15. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death.
Guerrero-Hue M; García-Caballero C; Palomino-Antolín A; Rubio-Navarro A; Vázquez-Carballo C; Herencia C; Martín-Sanchez D; Farré-Alins V; Egea J; Cannata P; Praga M; Ortiz A; Egido J; Sanz AB; Moreno JA
FASEB J; 2019 Aug; 33(8):8961-8975. PubMed ID: 31034781
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and inflammasome activation in human rhabdomyolysis-induced acute kidney injury.
Grivei A; Giuliani KTK; Wang X; Ungerer J; Francis L; Hepburn K; John GT; Gois PFH; Kassianos AJ; Healy H
Free Radic Biol Med; 2020 Nov; 160():690-695. PubMed ID: 32942024
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway.
Yang SK; Han YC; He JR; Yang M; Zhang W; Zhan M; Li AM; Li L; Na-Song ; Liu YT; Wu XQ; Zhang Q; Wang JW; Zhang H
Biomed Pharmacother; 2020 Oct; 130():110521. PubMed ID: 32717631
[TBL] [Abstract][Full Text] [Related]
18. Synergistic renal protection by combining alkaline-diuresis with lipid peroxidation inhibitors in rhabdomyolysis: possible interaction between oxidant and non-oxidant mechanisms.
Salahudeen AK; Wang C; Bigler SA; Dai Z; Tachikawa H
Nephrol Dial Transplant; 1996 Apr; 11(4):635-42. PubMed ID: 8671851
[TBL] [Abstract][Full Text] [Related]
19. Allopurinol attenuates rhabdomyolysis-associated acute kidney injury: Renal and muscular protection.
Gois PHF; Canale D; Volpini RA; Ferreira D; Veras MM; Andrade-Oliveira V; Câmara NOS; Shimizu MHM; Seguro AC
Free Radic Biol Med; 2016 Dec; 101():176-189. PubMed ID: 27769920
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline and thiamine ameliorate rhabdomyolysis-induced acute kidney injury in rats via suppressing TLR4/NF-κB and NLRP-3/caspase-1/gasdermin mediated-pyroptosis.
Al-Kharashi L; Attia H; Alsaffi A; Almasri T; Arafa M; Hasan I; Alajami H; Ali R; Badr A
Toxicol Appl Pharmacol; 2023 Feb; 461():116387. PubMed ID: 36690085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
